Clinical Notes: Drug Chosen for Major AD Study
(MedPage Today) -- The investigational anti-amyloid drug solanezumab will be tested in a landmark Alzheimer's disease prevention trial. Also this week: "bait bottles" to catch drug thieves.
Tags:
Clinical Notes: Drug Chosen for Major AD Study,
Alzheimer's Disease Latest News